Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01388777 · ClinicalTrials.gov registry record · Phase 2
Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT01388777: Clinical Trial Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT01388777 is a Phase 2 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01388777, a Phase 2 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Cryoablation is a procedure that uses a hollow, thin tube called a cryoprobe to freeze and destroy cancer tissue. The goal of this clinical research study is to learn about the level of effectiveness of using ultrasound-guided cryoablation in patients with invasive breast cancer. The safety of this procedure will also be studied.
Interventions
- PROCEDURE Surgical Resection
- PROCEDURE Cryoablation
- DEVICE Visica 2™ Treatment System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-01-24 |
| Est. Completion | 2017-06-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01388777
The ClinicalTrials.gov registry entry for NCT01388777 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Surgical Resection is the first listed.
NCT01388777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01388777 about?
NCT01388777 is a clinical study titled "Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy". Cryoablation is a procedure that uses a hollow, thin tube called a cryoprobe to freeze and destroy cancer tissue. The goal of this clinical research study is to learn about the level of effectiveness of using ultrasound-guided cryoablation in patients with invasive breast cancer. The safety of this...
What is the current status of trial NCT01388777?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2012-01-24. Estimated completion is 2017-06-14.
What interventions are being tested in trial NCT01388777?
The interventions under investigation include: Surgical Resection (PROCEDURE), Cryoablation (PROCEDURE), Visica 2™ Treatment System (DEVICE).
Who is sponsoring clinical trial NCT01388777?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.